Metropolitan Life Insurance Company (MetLife)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-17,857
Closed -$1.74M 2738
2015
Q1
$1.74M Buy
17,857
+1,272
+8% +$124K 0.01% 935
2014
Q4
$1.54M Hold
16,585
0.01% 1076
2014
Q3
$1.14M Hold
16,585
0.01% 1196
2014
Q2
$1.74M Buy
16,585
+863
+5% +$90.4K 0.01% 1052
2014
Q1
$1.3M Hold
15,722
0.01% 1168
2013
Q4
$1.02M Buy
15,722
+1,863
+13% +$121K 0.01% 1318
2013
Q3
$877K Hold
13,859
0.01% 1357
2013
Q2
$582K Buy
+13,859
New +$582K ﹤0.01% 1600